ec/ojs/index.php/RevHJCA/article/view/70
30. Arévalo EF. Grasa visceral medida por bioimpedancia y prevalencia de prediabetes medida en sangre en estudiantes de la Pontificia Universidad Católica del Ecuador de 19 a 25 años de edad en el periodo de octubre-noviembre 2015. Pontificia Universidad Católica del Ecuador; 2016.
31. Corella Galarza R. Factores de riesgo en el desarrollo de diabetes mellitus tipo 2 y su incidencia en personas mayores a 45 años del centro de la parroquia San Miguelito del cantón Píllaro período Julio-Noviembre 2014 [Internet]. Universidad Técnica de Ambato; 2015 [cited 2016 Jun 4]. Available from: http://repositorio.uta.edu.ec/bitstream/123456789/16115/2/Tesis Corella Galarza, Roberto Carlos.pdf
32. Asociación Latinoamericana de Diabetes. Guías ALAD sobre el Diagnóstico, Control y Tratamiento de la Diabetes Mellitus Tipo 2 con Medicina Basada en Evidencia. Rev la Asoc Latinoam Diabetes. 2013;17–8.
33. International Diabetes Federation. IDF Diabetes Atlas Sixth edition. Int Diabetes Fed. 2014;1–2.
34. Freire W, Belmont P, Gómez L, Mendieta M, Monge R, Piñeiros P, et al. Encuesta Nacional de Salud y Nutrición. ENSANUT-ECU 2012. Tomo I. Ministero de Salud Pública, Instituto Nacional de Estadísticas y Censos, editors. Quito, Ecuador: El telégrafo; 2014. 718 p.
35. Færch K, Borch-Johnsen K, Holst JJ, Vaag A. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: Does it matter for prevention and treatment of type 2 diabetes? Diabetologia. 2009;52(9):1714–23.
36. Rydén L, Grant P, Anker S, Berne C, Cosentino F, Danchin N, et al. Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Society for the Study of Diabetes. Rev Española Cardiol [Internet]. 2014;67(02):1–56. Available from: http://www.revespcardiol.org/es/guia-practica-clinica-esc-sobre/articulo/90267575/
37. Ford ES, Zhao G, Li C. Pre-Diabetes and the Risk for Cardiovascular Disease. A Systematic Review of the Evidence. J Am Coll Cardiol. Elsevier Inc.; 2010;55(13):1310–7.
38. Giráldez-García C, García-Soidán FJ, Serrano Martín R, Carrillo L, Sangrós González FJ, Franch Nadal J, et al. Evolución de pacientes con prediabetes en Atención Primaria de Salud (PREDAPS): resultados del primer año de seguimiento. Diabetes Práctica. 2014;05(1):1–48.
39. Gomez-Arbelaez D, Sánchez-Vallejo G, Perez M, Garcia RG, Arguello JF, Peñaherrera E, et al. Hiperglucemia se asocia a mayor número de desenlaces adversos en individuos latinoamericanos con infarto agudo de miocardio. Clin e Investig en Arterioscler. 2016;28(1):9–18.
40. Lee CC, Perkins BA, Kayaniyil S, Harris SB, Retnakaran R, Gerstein HC, et al. Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort. Diabetes Care [Internet]. American Diabetes Association; 2015 May [cited 2016 Jun 26];38(5):793–800. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25665810
41. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, et al. Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care [Internet]. American Diabetes Association; 2000 Aug [cited 2016 Jun 30];23(8):1113–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10937507
42. Holm N-CR, Belstrøm D, Østergaard JA, Schou S, Holmstrup P, Grauballe MB. Identification of Individuals With Undiagnosed Diabetes and Pre-Diabetes in a Danish Cohort Attending Dental Treatment. J Periodontol [Internet]. 2016 Apr [cited 2016 Jun 29];87(4):395–402. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26745612
43. Ohara T, Doi Y, Ninomiya T, Hirakawa Y, Hata J, Iwaki T, et al. Glucose tolerance status and risk of dementia in the community: The Hisayama Study. Neurology [Internet]. Lippincott Williams & Wilkins; 2011 Sep 20 [cited 2016 Jul 5];77(12):1126–34. Available from: http://www.neurology.org/cgi/doi/10.1212/WNL.0b013e31822f0435
44. Hill JO, Galloway JM, Goley A, Marrero DG, Minners R, Montgomery B, et al. Scientific statement: Socioecological determinants of prediabetes and type 2 diabetes. Diabetes Care [Internet]. American Diabetes Association; 2013 Aug [cited 2016 Jul 4];36(8):2430–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23788649
45. IMAGE Toolkit working group, Lindström J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, et al. Take action to prevent diabetes. A toolkit for the prevention of type 2 diabetes in Europe [Internet]. Vol. 42, Hormone and Metabolic Research. 2010. 1-88 p. Available from: papers2://publication/uuid/6D2543B8-0E16-44B6-948B-5887FA96F07B
46. Ayyavoo A, Savage T, Derraik JGB, Hofman PL, Cutfield WS. First-born children have reduced insulin sensitivity and higher daytime blood pressure compared to later-born children. J Clin Endocrinol Metab [Internet]. 2013 Mar [cited 2016 Mar 23];98(3):1248–53. Available from: http://press.endocrine.org/doi/abs/10.1210/jc.2012-3531
47. American Heart Association News. Eating more homemade meals may reduce risk of Type 2 diabetes [Internet]. 2015. Available from: http://news.heart.org/eating-more-homemade-meals-may-reduce-risk-of-type-2-diabetes/
48. Zhang L, Curhan GC, Hu FB, Rimm EB, Forman JP. Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care. 2011;34(4):892–7.
49. Lindtner C, Scherer T, Zielinski E, Filatova N, Fasshauer M, Tonks NK, et al. Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action. Sci Transl Med [Internet]. 2013 Jan 30 [cited 2016 Jan 21];5(170):170ra14. Available from: http://stm.sciencemag.org/content/5/170/170ra14
50. Whiting D, Unwin N, Roglic G. Diabetes: equity and social determinants. In: Blas E, Sivasankara Kurup A, editors. Equity, social determinants and public health programmes [Internet]. 2010 [cited 2016 Jul 21]. Available from: http://www.who.int/social_determinants/
51. Annis AM, Caulder MS, Cook ML, Duquette D. Family history, diabetes, and other demographic and risk factors among participants of the National Health and Nutrition Examination Survey 1999-2002. Prev Chronic Dis [Internet]. 2005 [cited 2016 Jun 22];2(2):A19. Available from: www.cdc.gov/pcd/ issues/2005/apr/04_0131.htm
52. Thiering E, Heinrich J. Epidemiology of air pollution and diabetes. Trends Endocrinol Metab [Internet]. Elsevier Ltd; 2015;26(7):384–94. Available from: http://www.sciencedirect.com/science/article/pii/S1043276015000843
53. Franch-Nadal J, Morató Griera J, Claret Torrents C. Diabetes y etnias. Badalona, España: Euromedicine; 2011.
54. Salazar DB, Carrasco LÁ. Prevalencia del síndrome metabólico con y sin la experiencia de emigración en la población de Zacatecas, México. Rev ALAD. 2016;6:87–93.
55. Hernandez A V., Pasupuleti V,